Virbac (VRBCF) has bolstered its specialty pet health portfolio by acquiring a world-leading feline hyperthyroidism treatment from Norbrook, valued at approximately £100 million. The development gives ...
We are delighted to announce the acquisition of a globally leading drug for the treatment of feline hyperthyroidism from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback